Literature DB >> 19631280

NKG2D and its ligands.

Peyman Obeidy1, Alexandra F Sharland.   

Abstract

NKG2D is an activating immunoreceptor, first recognized on NK cells but subsequently found on gammadelta T cells, CD8(+) alphabeta T cells and macrophages. In NK cells, inhibitory signals are generally dominate over activating signals. However, activating signals mediated through engagement of NKG2D by its ligands on target cells can bypass signals transmitted through inhibitory NK receptors, allowing NKG2D to function as a "master-switch" in determining the activation status of NK cells. NKG2D is important for T cell and NK cell-mediated immunity to viruses and tumours, and has roles in autoimmune disease, allogeneic transplantation, and xenotransplantation. Depending upon the situation, development of strategies to either block or to enhance the interactions between NKG2D and its ligands may have important implications for human health and disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631280     DOI: 10.1016/j.biocel.2009.07.005

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  24 in total

1.  Combining different design strategies for rational affinity maturation of the MICA-NKG2D interface.

Authors:  Samuel H Henager; Melissa A Hale; Nicholas J Maurice; Erin C Dunnington; Carter J Swanson; Megan J Peterson; Joseph J Ban; David J Culpepper; Luke D Davies; Lisa K Sanders; Benjamin J McFarland
Journal:  Protein Sci       Date:  2012-08-10       Impact factor: 6.725

2.  Culturing of human nasal epithelial cells at the air liquid interface.

Authors:  Loretta Müller; Luisa E Brighton; Johnny L Carson; William A Fischer; Ilona Jaspers
Journal:  J Vis Exp       Date:  2013-10-08       Impact factor: 1.355

3.  Cowpox virus induces interleukin-10 both in vitro and in vivo.

Authors:  April H Spesock; Brice E Barefoot; Caroline A Ray; Daniel J Kenan; Michael D Gunn; Elizabeth A Ramsburg; David J Pickup
Journal:  Virology       Date:  2011-06-11       Impact factor: 3.616

Review 4.  Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function.

Authors:  Sunil K Joshi; Mark L Lang
Journal:  Int Immunopharmacol       Date:  2013-06-22       Impact factor: 4.932

5.  Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice.

Authors:  Yaya Chu; Ashlin Yahr; Brian Huang; Janet Ayello; Matthew Barth; Mitchell S Cairo
Journal:  Oncoimmunology       Date:  2017-06-20       Impact factor: 8.110

6.  S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.

Authors:  Krystal Colón; David W Speicher; Peter Smith; Mack Taylor; David S Metzger; Luis J Montaner; Costin Tomescu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

Review 7.  Role of NKG2D and its ligands in cancer immunotherapy.

Authors:  Huifang Liu; Sijia Wang; Jing Xin; Jing Wang; Cuiping Yao; Zhenxi Zhang
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

8.  STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2 cells.

Authors:  Xiaohui Cai; Xuzhang Lu; Zhuxia Jia; Xiuwen Zhang; Wenmin Han; Xiao Rong; Lingdi Ma; Min Zhou; Baoan Chen
Journal:  Int J Hematol       Date:  2015-09-19       Impact factor: 2.490

9.  Ozone exposed epithelial cells modify cocultured natural killer cells.

Authors:  Loretta Müller; Luisa E Brighton; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-12-14       Impact factor: 5.464

10.  Enhancing cytokine-induced killer cell therapy of multiple myeloma.

Authors:  Chunsheng Liu; Lukkana Suksanpaisan; Yun-Wen Chen; Stephen J Russell; Kah-Whye Peng
Journal:  Exp Hematol       Date:  2013-02-08       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.